IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Abattis Bioceuticals Corp (ATTBF)

CUSIP: 00258G103 | NYSE | Healthcare · Drug Manufacturers - Specialty & Generic | Micro Cap | 7 institutional holders

Quarters

Q1 2026Q2 2025Q2 2023Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q1 2026

VSM Wealth Advisory, LLC1,200
0.0% of portfolio›$0
StyleTurnoverLocationFiled
VSM Wealth Advisory, LLC
1,200$00.0%ETFMediumHunt Valley, MD2026-05-06